Menu
GeneBe

3-50318160-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_003773.5(HYAL2):c.1391T>A(p.Leu464Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

HYAL2
NM_003773.5 missense

Scores

5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
HYAL2 (HGNC:5321): (hyaluronidase 2) This gene encodes a weak acid-active hyaluronidase. The encoded protein is similar in structure to other more active hyaluronidases. Hyaluronidases degrade hyaluronan, one of the major glycosaminoglycans of the extracellular matrix. Hyaluronan and fragments of hyaluronan are thought to be involved in cell proliferation, migration and differentiation. Although it was previously thought to be a lysosomal hyaluronidase that is active at a pH below 4, the encoded protein is likely a GPI-anchored cell surface protein. This hyaluronidase serves as a receptor for the oncogenic virus Jaagsiekte sheep retrovirus. The gene is one of several related genes in a region of chromosome 3p21.3 associated with tumor suppression. This gene encodes two alternatively spliced transcript variants which differ only in the 5' UTR.[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HYAL2NM_003773.5 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 4/4 ENST00000357750.9
HYAL2NM_033158.5 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 5/5
HYAL2XM_005265524.3 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 5/5
HYAL2XM_005265525.3 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HYAL2ENST00000357750.9 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 4/41 NM_003773.5 P1
HYAL2ENST00000395139.7 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 4/41 P1
HYAL2ENST00000447092.5 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 3/31 P1
HYAL2ENST00000442581.1 linkuse as main transcriptc.1391T>A p.Leu464Gln missense_variant 5/52 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 14, 2021The c.1391T>A (p.L464Q) alteration is located in exon 5 (coding exon 3) of the HYAL2 gene. This alteration results from a T to A substitution at nucleotide position 1391, causing the leucine (L) at amino acid position 464 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.38
Cadd
Benign
19
Dann
Uncertain
0.98
DEOGEN2
Benign
0.41
T;T;T;T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.50
N
M_CAP
Benign
0.015
T
MetaRNN
Uncertain
0.59
D;D;D;D
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
M;M;M;M
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-2.1
N;N;N;N
REVEL
Benign
0.17
Sift
Uncertain
0.0060
D;D;D;D
Sift4G
Uncertain
0.022
D;D;D;D
Polyphen
0.61
P;P;P;P
Vest4
0.53
MutPred
0.54
Gain of catalytic residue at L464 (P = 0.0011);Gain of catalytic residue at L464 (P = 0.0011);Gain of catalytic residue at L464 (P = 0.0011);Gain of catalytic residue at L464 (P = 0.0011);
MVP
0.65
MPC
0.86
ClinPred
0.52
D
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-50355591; API